Alamar Biosciences, Inc.
30.69USD
+0.9700 (+3.26%)
Fetching financial statements from SEC filings…
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on ALMR.
| In $M except per-share | Q2 FY26 | Q1 FY26 | Q2 FY25 | Q1 FY25 |
|---|---|---|---|---|
| Revenue | 29 | 26 | 16 | 13 |
| Cost of Revenue | 12 | 12 | 8 | 7 |
| Gross Profit | 18 | 14 | 9 | 6 |
| Operating Income | -14 | -12 | -8 | -9 |
| Net Income | -13 | -21 | -7 | -8 |
| EPS (Diluted) | -$0.22 | -$1.74 | -$0.62 | -$0.68 |
Source: SEC filings (EDGAR)